BioScience Managers
As an international healthcare investment firm that finances and enables innovative science and technology with the potential to transform healthcare, we have a team with the ambition and experience to deliver impressive investment returns.
Latest news
- Adherium appoints Mr Geoff Feakes as Chief Technology Officer 5 August 2020
- Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections 27 July 2020
- CalciMedica and EpiPharma Enter into Research Collaboration to Discover and Develop CRAC Channel Inhibitor Therapies 24 July 2020